Cargando…

Long Non-Coding RNAs as Molecular Signatures for Canine B-Cell Lymphoma Characterization

Background: Diffuse large B-cell lymphoma (DLBCL), marginal zone lymphoma (MZL) and follicular lymphoma (FL) are the most common B-cell lymphomas (BCL) in dogs. Recent investigations have demonstrated overlaps of these histotypes with the human counterparts, including clinical presentation, biologic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cascione, Luciano, Giudice, Luca, Ferraresso, Serena, Marconato, Laura, Giannuzzi, Diana, Napoli, Sara, Bertoni, Francesco, Giugno, Rosalba, Aresu, Luca
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789837/ https://www.ncbi.nlm.nih.gov/pubmed/31546795 http://dx.doi.org/10.3390/ncrna5030047

Ejemplares similares

Mutational landscape of canine B-cell lymphoma profiled at single nucleotide resolution by RNA-seq
por: Giannuzzi, Diana, et al.
Publicado: (2019)

DNA methylation profiling reveals common signatures of tumorigenesis and defines epigenetic prognostic subtypes of canine Diffuse Large B-cell Lymphoma
por: Ferraresso, Serena, et al.
Publicado: (2017)

Phenotypical Characterization and Clinical Outcome of Canine Burkitt-Like Lymphoma
por: Aresu, Luca, et al.
Publicado: (2021)

DNA Copy Number Changes in Diffuse Large B Cell Lymphomas
por: Cascione, Luciano, et al.
Publicado: (2020)

Epigenetic Silencing of TFPI-2 in Canine Diffuse Large B-Cell Lymphoma
por: Ferraresso, Serena, et al.
Publicado: (2014)

Array-Based Comparative Genomic Hybridization Analysis Reveals Chromosomal Copy Number Aberrations Associated with Clinical Outcome in Canine Diffuse Large B-Cell Lymphoma
por: Aricò, Arianna, et al.
Publicado: (2014)

Validation of epigenetic mechanisms regulating gene expression in canine B-cell lymphoma: An in vitro and in vivo approach
por: Da Ros, Silvia, et al.
Publicado: (2018)

Transformation of Canine Lymphoma/Leukemia to More Aggressive Diseases: Anecdotes or Reality?
por: Comazzi, Stefano, et al.
Publicado: (2015)

Exon–Intron Differential Analysis Reveals the Role of Competing Endogenous RNAs in Post-Transcriptional Regulation of Translation
por: Munz, Nicolas, et al.
Publicado: (2021)

A First NGS Investigation Suggests No Association Between Viruses and Canine Cancers
por: Giannuzzi, Diana, et al.
Publicado: (2020)

POT1 mutations are frequent and associated with Ki-67 index in canine diffuse large B-cell lymphoma
por: Fanelli, Antonella, et al.
Publicado: (2022)

Prognostic Value of PD-L1, PD-1 and CD8A in Canine Diffuse Large B-Cell Lymphoma Detected by RNAscope
por: Aresu, Luca, et al.
Publicado: (2021)

Canine Lymphoma, More Than a Morphological Diagnosis: What We Have Learned about Diffuse Large B-Cell Lymphoma
por: Aresu, Luca
Publicado: (2016)

Feline and Canine Cutaneous Lymphocytosis: Reactive Process or Indolent Neoplastic Disease?
por: Albanese, Francesco, et al.
Publicado: (2022)

IL-1R8 Downregulation and Concomitant TLR7 and TLR9 Upregulation Are Related to the Pathogenesis of Canine Diffuse Large B-Cell Lymphoma
por: Riva, Federica, et al.
Publicado: (2022)

Genomic and Transcriptomic Characterization of Canine Osteosarcoma Cell Lines: A Valuable Resource in Translational Medicine
por: Gola, Cecilia, et al.
Publicado: (2021)

MIDClass: Microarray Data Classification by Association Rules and Gene Expression Intervals
por: Giugno, Rosalba, et al.
Publicado: (2013)

Correction to: cuRnet: an R package for graph traversing on GPU
por: Bonnici, Vincenzo, et al.
Publicado: (2018)

cuRnet: an R package for graph traversing on GPU
por: Bonnici, Vincenzo, et al.
Publicado: (2018)

Clinical and Clinical Pathological Presentation of 310 Dogs Affected by Lymphoma with Aberrant Antigen Expression Identified via Flow Cytometry
por: Celant, Elena, et al.
Publicado: (2022)

The Novel TORC1/2 Kinase Inhibitor PQR620 Has Anti-Tumor Activity in Lymphomas as a Single Agent and in Combination with Venetoclax
por: Tarantelli, Chiara, et al.
Publicado: (2019)

Esearch3D: propagating gene expression in chromatin networks to illuminate active enhancers
por: Heer, Maninder, et al.
Publicado: (2023)

miR-Synth: a computational resource for the design of multi-site multi-target synthetic miRNAs
por: Laganà, Alessandro, et al.
Publicado: (2014)

The role of inflammation and matrix metalloproteinases in equine endometriosis
por: Aresu, Luca, et al.
Publicado: (2012)

KLF4, DAPK1 and SPG20 promoter methylation is not affected by DNMT1 silencing and hypomethylating drugs in lymphoma cells
por: Frazzi, Raffaele, et al.
Publicado: (2022)

Opportunities and challenges of active immunotherapy in dogs with B-cell lymphoma: a 5-year experience in two veterinary oncology centers
por: Marconato, Laura, et al.
Publicado: (2019)

Fido-SNP: the first webserver for scoring the impact of single nucleotide variants in the dog genome
por: Capriotti, Emidio, et al.
Publicado: (2019)

Comprehensive Reconstruction and Visualization of Non-Coding Regulatory Networks in Human
por: Bonnici, Vincenzo, et al.
Publicado: (2014)

The role of vascular endothelial growth factor and matrix metalloproteinases in canine lymphoma: in vivo and in vitro study
por: Aricò, Arianna, et al.
Publicado: (2013)

Enhancer RNAs (eRNAs) in Cancer: The Jacks of All Trades
por: Napoli, Sara, et al.
Publicado: (2022)

Sleeping Beauty: Anesthesia May Promote Relapse in Dogs With Diffuse Large B-Cell Lymphoma in Complete Remission After Chemo-Immunotherapy
por: Faroni, Eugenio, et al.
Publicado: (2021)

Vet-ICD-O-Canine-1, a System for Coding Canine Neoplasms Based on the Human ICD-O-3.2
por: Pinello, Katia, et al.
Publicado: (2022)

Performance of lymph node cytopathology in diagnosis and characterization of lymphoma in dogs
por: Martini, Valeria, et al.
Publicado: (2021)

Hypermethylation-Mediated Silencing of CIDEA, MAL and PCDH17 Tumour Suppressor Genes in Canine DLBCL: From Multi-Omics Analyses to Mechanistic Studies
por: Zorzan, Eleonora, et al.
Publicado: (2022)

Pharmacologic screen identifies active combinations with BET inhibitors and LRRK2 as a novel putative target in lymphoma
por: Spriano, Filippo, et al.
Publicado: (2022)

Prediction of human targets for viral-encoded microRNAs by thermodynamics and empirical constraints
por: Laganà, Alessandro, et al.
Publicado: (2010)

Comparison of non-coding RNAs in human and canine cancer
por: Wagner, Siegfried, et al.
Publicado: (2013)

The bromodomain and extra-terminal domain degrader MZ1 exhibits preclinical anti-tumoral activity in diffuse large B-cell lymphoma of the activated B cell-like type
por: Tarantelli, Chiara, et al.
Publicado: (2021)

Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphoma
por: Mensah, Afua A., et al.
Publicado: (2018)

Non-Coding RNAs in Hodgkin Lymphoma
por: Cordeiro, Anna, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_n1ppm04pa9vq9mlb8733gj6llp